JP2025509285A5 - - Google Patents

Info

Publication number
JP2025509285A5
JP2025509285A5 JP2024553392A JP2024553392A JP2025509285A5 JP 2025509285 A5 JP2025509285 A5 JP 2025509285A5 JP 2024553392 A JP2024553392 A JP 2024553392A JP 2024553392 A JP2024553392 A JP 2024553392A JP 2025509285 A5 JP2025509285 A5 JP 2025509285A5
Authority
JP
Japan
Prior art keywords
sequence ids
sequence
antigen
monoclonal antibody
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024553392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025509285A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/063801 external-priority patent/WO2023172881A1/en
Publication of JP2025509285A publication Critical patent/JP2025509285A/ja
Publication of JP2025509285A5 publication Critical patent/JP2025509285A5/ja
Pending legal-status Critical Current

Links

JP2024553392A 2022-03-07 2023-03-06 ｈＭＰＶ抗体およびそれらの使用 Pending JP2025509285A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263317384P 2022-03-07 2022-03-07
US63/317,384 2022-03-07
PCT/US2023/063801 WO2023172881A1 (en) 2022-03-07 2023-03-06 Hmpv antibodies and their use

Publications (2)

Publication Number Publication Date
JP2025509285A JP2025509285A (ja) 2025-04-11
JP2025509285A5 true JP2025509285A5 (cg-RX-API-DMAC7.html) 2026-02-13

Family

ID=87935885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024553392A Pending JP2025509285A (ja) 2022-03-07 2023-03-06 ｈＭＰＶ抗体およびそれらの使用

Country Status (7)

Country Link
US (1) US20250188153A1 (cg-RX-API-DMAC7.html)
EP (1) EP4490180A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025509285A (cg-RX-API-DMAC7.html)
CN (1) CN119213024A (cg-RX-API-DMAC7.html)
AU (1) AU2023232815A1 (cg-RX-API-DMAC7.html)
CA (1) CA3254336A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023172881A1 (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020236974A1 (en) * 2019-05-21 2020-11-26 University Of Georgia Research Foundation, Inc. Antibodies that bind human metapneumovirus fusion protein and their use

Similar Documents

Publication Publication Date Title
JP7235256B2 (ja) 重症熱性血小板減少症候群ウイルスの外膜糖タンパク質に結合する抗体及びその用途
JP2021526022A5 (cg-RX-API-DMAC7.html)
JP2024506315A5 (cg-RX-API-DMAC7.html)
JP2025067915A5 (cg-RX-API-DMAC7.html)
CN119431565B (zh) 一种抗hpv16型e6蛋白和e7蛋白的抗体、检测产品及其应用
JP2025506172A5 (cg-RX-API-DMAC7.html)
IL314799A (en) Human monoclonal antibodies that broadly target coronaviruses
JP2025505650A5 (cg-RX-API-DMAC7.html)
CN117143238A (zh) 抗人cd24抗体及其应用
CN114578066B (zh) 检测β-淀粉样蛋白的产品和方法
CN114594272B (zh) 用于检测β-淀粉样蛋白的产品和方法
CN119431564B (zh) 一种抗hpv16型e6蛋白和e7蛋白的抗体或其抗原结合片段、hpv16检测产品及其应用
CN114805570B (zh) 一种抗人ace2单克隆抗体及其应用
CN107586336A (zh) 针对寨卡病毒的全人源单克隆抗体及应用
CN117603348B (zh) 抗新型冠状病毒s蛋白的全人源化抗体及其应用
JP2025509285A5 (cg-RX-API-DMAC7.html)
CN116410309B (zh) 特异性结合脊髓灰质炎病毒iii型抗原的抗体
CN118496351B (zh) 特异性结合柯萨奇病毒a6的单克隆抗体及其用途
CN117603346A (zh) 全人源新型冠状病毒单克隆抗体及其应用
CN114213541B (zh) 一种全能核酸酶的单克隆抗体及其制备方法
CN114605532B (zh) 抗β-淀粉样蛋白抗体及其用途
JP2024536358A5 (cg-RX-API-DMAC7.html)
KR20230124280A (ko) 메르스 코로나 바이러스의 뉴클레오캡시드 단백질에 특이적인 진단용 항체 및 이의 용도
WO2022079359A1 (en) Sars-cov-2 coronavirus-neutralizing antibody
JP2024502670A5 (cg-RX-API-DMAC7.html)